Pharmacokinetic and Comparative Bioavailability Study of Testosterone Absorption After Administration of Testosterone Gel 1.62% to the Upper Arms/Shoulders Using an Application Site Rotation or a Combination of Application Sites in Hypogonadal Males

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions

Hypogonadism

Interventions

DRUG

Testosterone Gel 1.62%

5 grams administered using an application Site Rotation

DRUG

Testosterone Gel 1.62%

5 grams administered using an a combination of Application sites